NCT04109664

Brief Summary

Aim: The impact of extended antral resection (AR) after laparoscopic sleeve gastrectomy (LSG) on weight loss changes and metabolic response is still not clearly elucidated with conflicting results. The investigator's retrospective cohort study aimed to determine whether AR is superior to antral preservation (AP) regarding weight loss and resolution of co-morbidities. Methods: Patients were divided into two groups according to the distance of gastric division as AR group (2cm from pylorus) and AP group (6cm from pylorus). Postoperative excess weight loss percentile (%EWL) and total body weight loss percentiles (%TBWL) at the end of first, 6th and 12 months were compared. Secondly, metabolic parameters and complications were compared.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
111

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

September 25, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 30, 2019

Completed
Last Updated

September 30, 2019

Status Verified

September 1, 2019

Enrollment Period

2.4 years

First QC Date

September 25, 2019

Last Update Submit

September 26, 2019

Conditions

Keywords

antral resectionsleeve gastrectomyexcess weight losstotal body weight loss

Outcome Measures

Primary Outcomes (12)

  • Glucose(mg/dl) change

    Preoperative fasting glucose (mg/dl) values compared with fasting glucose (mg/dl) values at 12 months.

    0, 12. month

  • Glycated hemoglobin(Hb A1c) (mmol/mol) change

    Preoperative glycated hemoglobin(Hb A1c) (mmol/mol) values compared with glycated hemoglobin(Hb A1c) (mmol/mol) values at 12 months.

    0, 12. month

  • C-Peptide(ng/ml) change

    Preoperative C-peptide (ngl/ml) values compared with C-peptide (ngl/ml) values at 12 months.

    0, 12. month

  • Insulin (mg/dl) change

    Preoperative Insulin (mg/dl) values compared with Insulin (mg/dl) values at 12 months.

    0, 12. month

  • Cholesterol (mg/dl) levels change

    Preoperative Cholesterol (mg/dl) values compared with Cholesterol (mg/dl) values at 12 months.

    0, 12. month

  • Triglyceride(mg/dl) levels change

    Preoperative Triglyceride(mg/dl) values compared with Triglyceride(mg/dl) values at 12 months.

    0, 12. month

  • HDL (mg/dl) levels change

    Preoperative HDL(mg/dl) values compared with HDL(mg/dl) values at 12 months.

    0, 12. month

  • LDL (mg/dl) levels change

    Preoperative LDL(mg/dl) values compared with LDL(mg/dl) values at 12 months.

    0, 12. month

  • VLDL (mg/dl) levels change

    Preoperative VLDL(mg/dl) values compared with VLDL(mg/dl) values at 12 months.

    0, 12. month

  • Resolution of co-morbidities

    Resolution of co-morbidities (hypertension, hyperlipidemia, diabetes type 2) was defined as reduction of co-morbidity related symptom and signs with change of specific biochemical blood tests to normal ranges. Preoperative status will be compared with 12.months status.

    0,12. month

  • Excess Weight Loss change

    The %Excess Weight Loss is calculated as \[(preoperative weight - follow up(1,6,12 month weight) / (preoperative weight-ideal weight)\] x100, with ideal weight based on a BMI of 25kg/m2.

    0,1,6, 12. month

  • The total body weight loss percentile change

    The total body weight loss percentile (%TBWL) is calculated as \[(preoperative weight - follow up(1,6,12. month weight) / (preoperative body weight)\] x100. ideal weight based on a BMI of 25kg/m2

    0,1,6, 12. month

Secondary Outcomes (1)

  • complication

    1 year

Study Arms (2)

antral preservation

The patients were grouped according to the distance of gastric division as Antral preservation group (6cm from pylorus)

Procedure: laparoscopic sleeve gastrectomy

Antral resection

The patients were grouped according to the distance of gastric division as Antral preservation group (2 cm from pylorus)

Procedure: laparoscopic sleeve gastrectomy

Interventions

The greater omentum is carefully dissected from the stomach at a distance of 2cm for the patients with AR, and 6cm for patients with AP. The omental dissection was performed using 5mm-abdominal ligature (Ligasure®, Metronic-Covidien, Minneapolis, USA), from the antrum towards the angle of His. Transection from the omentum is continued until the left crus has been identified. All sleeves are transected using 36 French orogastric tubes. Green cartridges (4.8 mm staple height) are used for the first firing and blue cartridges (3.5 mm) for the rest. Neither oversewing sutures to the staple line nor staple line reinforcement products are used. Homeostatic metallic clips are used for bleeding at the staple line. If bleeding persists and cannot be controlled, an interrupted suture is performed at the point of bleeding. A leak test with methylene blue is performed to the gastric remnant to assess the integrity of the suture line.

Antral resectionantral preservation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who underwent Laparoscopic Sleeve Gastrectomy between January 2016 and June 2018 are retrospectively analyzed.

You may qualify if:

  • Patients with Body Mass Index \> 40 were included

You may not qualify if:

  • Patients with a history of previous bariatric surgery and patients who did not attend regular follow-up visits (first, 6th and 12 months) are excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kocaeli Derince Training and research Hospital

Kocasinan, Derince, 41900, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Obesity, Morbid

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D. Department of Gastroenterological surgery,Principal Investigator

Study Record Dates

First Submitted

September 25, 2019

First Posted

September 30, 2019

Study Start

January 1, 2016

Primary Completion

June 1, 2018

Study Completion

July 1, 2018

Last Updated

September 30, 2019

Record last verified: 2019-09

Locations